Results 21 to 30 of about 45,508 (290)
Shifts in medical cannabis use in Canada during the COVID-19 pandemic
Health Promotion and Chronic Disease Prevention in Canada, 2023 IntroductionThe COVID-19 pandemic has had widespread secondary negative health impacts including loss of material security and exacerbation of mental illness in at-risk populations.
Stephanie Lake +3 more
doaj +1 more source
Puff, Puff, Don’t Pass: harm reduction for cannabis use during a viral respiratory pandemic
Harm Reduction Journal, 2023 Background Prior to the COVID-19 pandemic, cannabis use social practices often involved sharing prepared cannabis (joints/blunts/cigarettes) and cannabis-related paraphernalia.
Ryan D. Assaf +5 more
doaj +1 more source
Biomolecules, 2023 In this review article, we embark on a thorough exploration of cannabinoids, compounds that have garnered considerable attention for their potential therapeutic applications. Initially, this article delves into the fundamental background of cannabinoids,
Victor Voicu +9 more
doaj +1 more source
The Skin and Natural Cannabinoids–Topical and Transdermal Applications
Pharmaceuticals, 2023 The chemical constituents of the Cannabis plant known as cannabinoids have been extensively researched for their potential therapeutic benefits. The use of cannabinoids applied to the skin as a potential method for both skin-related benefits and systemic
Silviu-Iulian Filipiuc +9 more
doaj +1 more source
Heteroadamantyl Cannabinoids [PDF]
Journal of Medicinal Chemistry, 2010 The aliphatic side chain plays a pivotal role in determining the cannabinergic potency of tricyclic classical cannabinoids. We have synthesized a series of analogues in which the C3 position is substituted either directly or through a one-carbon atom linker with an adamantylamine or with an oxa- or an oxazaadamantane. The oxaadamantane pharmacophore in
Darryl D, Dixon +8 more
openaire +2 more sources
BMJ Case Reports, 2010 A 21-year-old woman presented with a 4-week history of sudden onset vomiting, nausea and anorexia. Questioning revealed that she had a 7-year history of heavy cannabis use (smoking). She did not describe abdominal pain, change in bowel habit, antibiotic use, foreign travel or contact with gastroenteritis.
Kim, Wild, Hugh, Wilson
openaire +3 more sources
Sex-dependent effects of in utero cannabinoid exposure on cortical function
eLife, 2018 Cannabinoids can cross the placenta, thus may interfere with fetal endocannabinoid signaling during neurodevelopment, causing long-lasting deficits.
Anissa Bara +11 more
doaj +1 more source
Cannabinoids Rescue Cocaine-Induced Seizures by Restoring Brain Glycine Receptor Dysfunction
Cell Reports, 2020 Summary: Cannabinoids are reported to rescue cocaine-induced seizures (CISs), a severe complication in cocaine users. However, the molecular targets for cannabinoid therapy of CISs remain unclear.
Guichang Zou +15 more
doaj +1 more source
Cannabinoids in the Treatment of Epilepsy: A Review
European Medical Journal, 2021 Cannabinoids have been studied for their role in the treatment of epilepsy for many years. The U.S. Food and Drug Administration (FDA) approved them for the treatment of some refractory syndromes in 2018.
Daniel Zhou +3 more
doaj +1 more source
The analysis of cannabinoids in e-cigarette liquids using LC-HRAM-MS and LC-UV
, 2023 The use of cannabidiol or CBD products has skyrocketed in the last five years due to the alleged therapeutic benefits, a low potential for abuse and lack of the typical psychoactive effects associated with the use of cannabis products containing high ...
Patricia Courselle +7 more
core +1 more source